Risk Evaluation and Mitigation Strategy (REMS): FDA Perspective on What Physicians Need to Know

Am Fam Physician. 2015 Nov 1;92(9):771-2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Medication Therapy Management*
  • Physician's Role
  • Product Surveillance, Postmarketing / methods*
  • Risk Assessment / methods*
  • United States
  • United States Food and Drug Administration*